Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-29

Clinical Trial Update: The Efficiency Of The Methotrexate At Patients Affected By Grave Pelade [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating methotrexate for alopecia areata has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: University Hospital, Rouen | Conditions: ALOPECIA AREATA | Phase 3 | Status: COMPLETED